2021
DOI: 10.1097/mao.0000000000003430
|View full text |Cite
|
Sign up to set email alerts
|

Usefulness of Cervical Vestibular-Evoked Myogenic Potentials for Diagnosing Patients With Superior Canal Dehiscence Syndrome: A Meta-Analysis

Abstract: Objectives: To compare the diagnostic accuracy of cervical vestibular-evoked myogenic potential (cVEMP) for detecting superior canal dehiscence (SCD) syndrome to that of computed tomography (CT) and surgical findings. Databases Reviewed: PubMed, SCOPUS, Embase, Web of Science, and the Cochrane database. Methods: Databases were searched up to July 2021. True positives, true negatives, false positives, and false negatives were extracted. Methodological quality was assessed using the Quality Assessment of Diagnos… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 50 publications
0
5
0
Order By: Relevance
“…This may be due to inconsistent reporting of thresholds at 250 Hz in routine audiograms. Moreover, abnormalities in oVEMPs and cVEMPs in the setting of SSCD are well-described in the literature ( Kim et al., 2022 ; Zuniga et al., 2013 ). Unfortunately, VEMP data was not collected in most patients without radiologic-confirmed superior canal dehiscence, which is an issue that has been raised in previous reports ( Welgampola et al., 2008 ; Janky et al., 2013 ; Hunter et al., 2017 ; Roditi et al., 2009 ; Lin et al., 2019 , 2021 ).…”
Section: Discussionmentioning
confidence: 94%
See 1 more Smart Citation
“…This may be due to inconsistent reporting of thresholds at 250 Hz in routine audiograms. Moreover, abnormalities in oVEMPs and cVEMPs in the setting of SSCD are well-described in the literature ( Kim et al., 2022 ; Zuniga et al., 2013 ). Unfortunately, VEMP data was not collected in most patients without radiologic-confirmed superior canal dehiscence, which is an issue that has been raised in previous reports ( Welgampola et al., 2008 ; Janky et al., 2013 ; Hunter et al., 2017 ; Roditi et al., 2009 ; Lin et al., 2019 , 2021 ).…”
Section: Discussionmentioning
confidence: 94%
“…Published evidence has identified factors that may be predictive of a diagnosis of SSCD, including cochlear symptoms ( Benamira et al., 2014 ), decreased thresholds on cVEMP ( Kim et al., 2022 ), increased oVEMP amplitudes ( Zhang et al., 2021 ), and low frequency CHL ( Zhang et al., 2021 ). While such clinical factors may be used to verify suspicion for SSCD independently, it again remains challenging to interpret in practice as patients often present with a quite varied combination of symptoms and objective findings ( Naert et al., 2018 ; Zhou et al., 2007 ).…”
Section: Introductionmentioning
confidence: 99%
“…7 Thus, radiographic imaging abnormalities alone do not indicate symptomatic SCD. Audiometric and vestibular testing, including supranormal bone conduction threshold testing and cervical or ocular vestibular evoked myogenic potential (VEMP) testing, 8 can clarify ambiguous cases. These can include patients with plausible alternative diagnoses and those with indeterminate radiographic dehiscence but convincing third window symptoms ("near dehiscence syndrome" 9,10 ).…”
Section: Introductionmentioning
confidence: 99%
“…Cervical vestibular evoked myogenic potential (cVEMP) recorded from the contracted sternocleidomastoid muscle (SCMM) is an objective, non-invasive, timesaving, reproducible and well-tolerated evaluation method, which can be selected as a screening test to evaluate the otolith function in young children ( 22 , 23 ). In terms of its evoked stimuli, air conducted sound (ACS), the most commonly used stimulus, is frequently used to elicit cVEMP.…”
Section: Introductionmentioning
confidence: 99%
“…However, ACS-cVEMP is not suitable for subjects with conductive hearing loss. In contrast, bone conducted vibration cVEMP (BCV-cVEMP) can bypass the middle ear, allowing to evaluate the saccule and inferior vestibular nerve pathway for subjects with middle ear pathology ( 10 , 23 , 26 ). Verrecchia et al ( 15 ) implemented BCV-cVEMP in infants aged 1–6 months who referred for the 2nd hearing screening due to the failure of the 1st hearing screening or had high risk factors of hearing loss, and those who came for diagnostic hearing assessment.…”
Section: Introductionmentioning
confidence: 99%